Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F- Sodium Fluoride PET Imaging as a Replacement for Bone Scintigraphy

NCT01930812 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT01930812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01930812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F- Sodium Fluoride PET Imaging as a Replacement for Bone Scintigraphy
Lead sponsor
British Columbia Cancer Agency
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2014
Completion date
March 31, 2019
Enrollment
286 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases from breast or prostate cancer